# 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma

> **NCT07590336** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-NYM207 PET/CT

## Key facts

- **NCT ID:** NCT07590336
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07590336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07590336, "68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-08-16 from https://api.ai-analytics.org/clinical/NCT07590336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*